8-K
Current Report
Foghorn Therapeutics Inc. Filed Acc 0001193125-20-278568
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading d71549d8k.htm…